0HOH.L
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clinical study program includes HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2018-01-29
Stock Exchange
LSE
Ticker
0HOH.L
According to bluebird bio, Inc.’s latest financial reports and current stock price. The company's current ROE is 1.90%. This represents a change of 629.95% compared to the average of 259.65% of the last 4 quarters.
The mean historical ROE of bluebird bio, Inc. over the last ten years is 11.10%. The current 1.90% ROE has changed 16.97% with respect to the historical average. Over the past ten years (40 quarters), 0HOH.L's ROE was at its highest in in the September 2024 quarter at 1.05%. The ROE was at its lowest in in the June 2024 quarter at -153.63%.
Average
11.10%
Median
-37.98%
Minimum
-218.92%
Maximum
763.35%
Discovering the peaks and valleys of bluebird bio, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 379.48%
Maximum Annual ROE = 763.35%
Minimum Annual Increase = -800.76%
Minimum Annual ROE = -218.92%
| Year | ROE | Change |
|---|---|---|
| 2024 | 763.35% | -800.76% |
| 2023 | -108.93% | -7.15% |
| 2022 | -117.32% | -46.41% |
| 2021 | -218.92% | 379.48% |
| 2020 | -45.66% | -25.70% |
| 2019 | -61.45% | 108.48% |
| 2018 | -29.48% | 42.56% |
| 2017 | -20.67% | -31.78% |
| 2016 | -30.31% | 54.55% |
| 2015 | -19.61% | 97.78% |
The current ROE of bluebird bio, Inc. (0HOH.L) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
179.03%
5-year avg
54.50%
10-year avg
11.10%
bluebird bio, Inc.’s ROE is greater than Zynerba Pharmaceuticals, Inc. (-59.45%), greater than MD Medical Group Investments Plc (18.39%), greater than Unity Biotechnology, Inc. (-273.74%), greater than Invitae Corporation (-201.69%), less than Endo International plc (45.54%), less than Palatin Technologies, Inc. (112.10%), greater than Cara Therapeutics, Inc. (-115.90%), less than Accelerate Diagnostics, Inc. (77.07%), greater than VivoSim Labs, Inc. (-33.01%), greater than Imunon, Inc. (-336.51%),
| Company | ROE | Market cap |
|---|---|---|
| -59.45% | N/A | |
| 18.39% | N/A | |
| -273.74% | N/A | |
| -201.69% | N/A | |
| 45.54% | N/A | |
| 112.10% | N/A | |
| -115.90% | N/A | |
| 77.07% | N/A | |
| -33.01% | N/A | |
| -336.51% | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like bluebird bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like bluebird bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is bluebird bio, Inc.'s ROE?
How is the ROE calculated for bluebird bio, Inc. (0HOH.L)?
What is the highest ROE for bluebird bio, Inc. (0HOH.L)?
What is the 3-year average ROE for bluebird bio, Inc. (0HOH.L)?
What is the 5-year average ROE for bluebird bio, Inc. (0HOH.L)?
How does the current ROE for bluebird bio, Inc. (0HOH.L) compare to its historical average?